Latest News
TetraScience collaborates with Thermo Fisher Scientific to accelerate scientific data and AI enablement
13 January 2026 - Scientific data and AI company TetraScience announced on Monday that it has formed a collaboration with life science and clinical research company Thermo Fisher Scientific Inc (NYSE:TMO).The partners aim to accelerate AI across biop...
Curasight reports preliminary data from Phase 1 trial in patients with high-grade gliomas
13 January 2026 - Curasight A/S (CPH:CURAS), a Denmark-based clinical stage radiopharmaceutical company, on Monday reported encouraging preliminary data from the first patient dosed in the ongoing Phase 1 uTREAT clinical trial in patients with high-g...
Abbisko Therapeutics reports US FDA acceptance of pimicotinib NDA
13 January 2026 - Abbisko Therapeutics Co Ltd (HKEX:02256), a China-based, oncology-focused biopharmaceutical company, announced on Monday that the US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for its novel, orall...
WuXi Biologics granted UK GMP certification for two manufacturing facilities in Wuxi
13 January 2026 - WuXi Biologics (HK:2269), a China-based global Contract Research, Development, and Manufacturing Organisation (CRDMO), announced on Monday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted GMP certif...
Viking Therapeutics publishes Phase 2 data showing up to 14.7% weight loss with VK2735
12 January 2026 - Biopharmaceutical company Viking Therapeutics Inc (NASDAQ: VKTX) on Monday announced publication of results from its Phase 2 VENTURE trial evaluating VK2735, a dual GLP-1/GIP receptor agonist, in the peer-reviewed journal Obesity. D...